[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"biomarker:forkhead-box-protein-g1":3},{"name":4,"total":5,"recruiting":6,"trials":7},"Forkhead Box Protein G1",3,2,[8,15,21],{"nct_id":9,"title":10,"phases":11,"status":12,"updated_at":13,"content_modified":14},"NCT06585605","A Retrospective Survey-based Multicenter Study to Delineate the Molecular and Phenotypic Spectrum of Epilepsy-dyskinesia Syndromes",[],"RECRUITING","2026-08-26T02:17:50.500039Z","2026-06-02T11:21:24.705937Z",{"nct_id":16,"title":17,"phases":18,"status":12,"updated_at":19,"content_modified":20},"NCT06967727","Registry and Natural History of Epilepsy-Dyskinesia Syndromes",[],"2026-08-26T02:18:36.226508Z","2026-05-13T02:55:06.602470Z",{"nct_id":22,"title":23,"phases":24,"status":26,"updated_at":27,"content_modified":28},"NCT07293546","Phase 1\u002F2 Study of FRF-001, an AAV-9 Gene Therapy, in Patients With FOXG1 Syndrome (FS)",[25],"Phase 1\u002FPhase 2","ENROLLING_BY_INVITATION","2026-08-26T02:16:54.044282Z","2026-07-30T01:46:14.438772Z"]